Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?

The paper is intended to deal with the regulatory status of the family of substance-based medical devices (SB-MD) which contain mucoadhesive polymers. Mucoadhesive formulations are mainly intended for oral/buccal, gastro-esophageal, nasal, or vaginal administration routes. They contain one or more s...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Vigani, Silvia Rossi, Giuseppina Sandri, Maria Cristina Bonferoni, Carla M. Caramella
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Drug Safety and Regulation
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1227763/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159968414203904
author Barbara Vigani
Silvia Rossi
Giuseppina Sandri
Maria Cristina Bonferoni
Carla M. Caramella
author_facet Barbara Vigani
Silvia Rossi
Giuseppina Sandri
Maria Cristina Bonferoni
Carla M. Caramella
author_sort Barbara Vigani
collection DOAJ
description The paper is intended to deal with the regulatory status of the family of substance-based medical devices (SB-MD) which contain mucoadhesive polymers. Mucoadhesive formulations are mainly intended for oral/buccal, gastro-esophageal, nasal, or vaginal administration routes. They contain one or more substances/polymers of either natural, synthetic or semi-synthetic origin endowed with mucoadhesive properties. These are complex substances whose chemical-physical properties are in general well characterized. Hydration and water retaining properties, gel formation, lubricating properties are example of functional characteristics that may be involved in mucosal interaction. However, there are still uncertainties as to the underlaying mechanisms. The idea is to provide support, to the understanding of the prevailing mechanisms of action of the family of SB-MD that exploit mucoadhesion phenomenon to exert the intended therapeutic action. A case study on Hyaluronic acid as a typical representative of mucoadhesive polymers, is presented. The correct understanding of the mechanism of action of the substances/polymers involved in SB-MD is pivotal to a smooth and successful submission to the involved regulatory bodies to a positive assessment and to the final approval.
format Article
id doaj-art-dad55d18c05e43d18de1ca79b805b3ab
institution Kabale University
issn 2674-0869
language English
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Drug Safety and Regulation
spelling doaj-art-dad55d18c05e43d18de1ca79b805b3ab2024-11-22T16:09:50ZengFrontiers Media S.A.Frontiers in Drug Safety and Regulation2674-08692023-08-01310.3389/fdsfr.2023.12277631227763Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?Barbara ViganiSilvia RossiGiuseppina SandriMaria Cristina BonferoniCarla M. CaramellaThe paper is intended to deal with the regulatory status of the family of substance-based medical devices (SB-MD) which contain mucoadhesive polymers. Mucoadhesive formulations are mainly intended for oral/buccal, gastro-esophageal, nasal, or vaginal administration routes. They contain one or more substances/polymers of either natural, synthetic or semi-synthetic origin endowed with mucoadhesive properties. These are complex substances whose chemical-physical properties are in general well characterized. Hydration and water retaining properties, gel formation, lubricating properties are example of functional characteristics that may be involved in mucosal interaction. However, there are still uncertainties as to the underlaying mechanisms. The idea is to provide support, to the understanding of the prevailing mechanisms of action of the family of SB-MD that exploit mucoadhesion phenomenon to exert the intended therapeutic action. A case study on Hyaluronic acid as a typical representative of mucoadhesive polymers, is presented. The correct understanding of the mechanism of action of the substances/polymers involved in SB-MD is pivotal to a smooth and successful submission to the involved regulatory bodies to a positive assessment and to the final approval.https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1227763/fullsubstance-based medical devicesmucoadhesionmucoadhesive polymersmechanismsregulation
spellingShingle Barbara Vigani
Silvia Rossi
Giuseppina Sandri
Maria Cristina Bonferoni
Carla M. Caramella
Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
Frontiers in Drug Safety and Regulation
substance-based medical devices
mucoadhesion
mucoadhesive polymers
mechanisms
regulation
title Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
title_full Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
title_fullStr Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
title_full_unstemmed Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
title_short Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
title_sort mucoadhesive polymers in substance based medical devices functional ingredients or what else
topic substance-based medical devices
mucoadhesion
mucoadhesive polymers
mechanisms
regulation
url https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1227763/full
work_keys_str_mv AT barbaravigani mucoadhesivepolymersinsubstancebasedmedicaldevicesfunctionalingredientsorwhatelse
AT silviarossi mucoadhesivepolymersinsubstancebasedmedicaldevicesfunctionalingredientsorwhatelse
AT giuseppinasandri mucoadhesivepolymersinsubstancebasedmedicaldevicesfunctionalingredientsorwhatelse
AT mariacristinabonferoni mucoadhesivepolymersinsubstancebasedmedicaldevicesfunctionalingredientsorwhatelse
AT carlamcaramella mucoadhesivepolymersinsubstancebasedmedicaldevicesfunctionalingredientsorwhatelse